Chen Au Peh
The University of Adelaide
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chen Au Peh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:24 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06120673 · REmission in Membranous Nephropathy International Trial (REMIT)The University of Queensland · withdrawn · Primary Membranous Nephropathy · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:24 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med · 20101,282 citationsRCR 38.8
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.N Engl J Med · 2020668 citationsRCR 41.3
- 267 citationsRCR 30.3
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.Ann Rheum Dis · 2015224 citationsRCR 9.1
- 177 citationsRCR 7.3
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.Ann Rheum Dis · 2019177 citationsRCR 9.9
- Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.Ann Rheum Dis · 2023109 citationsRCR 13.9
- Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis.Nephrology (Carlton) · 201530 citationsRCR 1.2
- The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women.J Am Geriatr Soc · 199318 citationsRCR 0.7
- Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.Health Technol Assess · 202211 citationsRCR 1.0